[Chronic toxicity study of latamoxef in beagle dog (author's transl)].
Chronic toxicity study of latamoxef (LMOX, 6059-S) by intravenous administration at dose levels of 100, 200 and 400 mg/kg daily for 6 months was carried out in adult Beagle dogs. All dogs of the 6059-S treated groups survived throughout the experimental period without showing any toxic signs other than occasional vomiting. Slight decrease of RBC, Ht, Hb and platelet, and increase of reticulocytes were noted in the 400 mg/kg group. Blood chemistry revealed decreased activity in GPT in the 6059-S treated groups, and increased contents of total protein and lipids in the 400 mg/kg group. These clinical changes were slight and transient in most instances. Liver and kidneys weights increased slightly without accompanying any pathological alterations. Inflammatory changes, probably due to mechanical irritation, were found in the subcutis and around the vein at the injection sites in all groups including the mannitol control group. From these results it is concluded that the maximum nontoxic dose in dogs is in the range of 200 to 400 mg/kg when the 6059-S was intravenously administered daily for 6 months.
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002511:Cephalosporins / Q000633:toxicity*; D002513:Cephamycins / Q000008:administration & dosage / Q000097:blood / Q000633:toxicity*; D004285:Dogs; D004435:Eating / Q000187:drug effects; D004562:Electrocardiography; D005260:Female; D006403:Hematologic Tests; D007668:Kidney / Q000648:ultrastructure; D008099:Liver / Q000648:ultrastructure; D008297:Male; D008854:Microscopy, Electron; D009070:Moxalactam; D009929:Organ Size / Q000187:drug effects
D002511:Cephalosporins; D002513:Cephamycins; D009070:Moxalactam